Aileron Therapeutics, Inc.

Rachunek Zysków i Strat





Przychody TTM (mln): 0
EBIT TTM (mln): -30
index 0 1 2 3 4 5 6 7 8 9 10
Rok finansowy 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Przychód (mln) 22 0 0 0 0 0 0 0 0 0 0
Przychód Δ r/r 0.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Marża brutto 45.3% -inf% 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% -inf%
EBIT (mln) 3 -16 -13 -18 -23 -32 -30 -20 -27 -28 -16
EBIT Δ r/r 0.0% -588.2% -19.6% 40.9% 26.6% 38.7% -6.1% -31.6% 29.8% 3.9% -41.1%
EBIT (%) 14.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 -0 0
EBITDA (mln) 4 -15 -13 -18 -23 -32 -30 -20 -27 -27 -16
EBITDA(%) 18.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Podatek (mln) 3 0 0 0 0 0 -1 1 -0 -0 0
Zysk Netto (mln) 0 -16 -13 -18 -23 -32 -29 -22 -26 -27 -16
Zysk netto Δ r/r 0.0% -8382.0% -19.8% 40.7% 24.7% 39.6% -8.8% -24.2% 18.1% 4.8% -41.8%
Zysk netto (%) 0.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
EPS 10.21 -845.63 -23.6 -33.21 -60.74 -42.81 -23.46 -12.52 -5.8 -5.95 -3.42
EPS (rozwodnione) 10.85 -844.96 -23.6 -33.21 -60.74 -42.81 -23.46 -12.52 -5.8 -5.95 -3.42
Ilośc akcji (mln) 0 0 1 1 0 1 1 2 4 5 5
Ważona ilośc akcji (mln) 0 0 1 1 0 1 1 2 4 5 5
Waluta USD USD USD USD USD USD USD USD USD USD USD